Search alternatives:
reduction decrease » reduction decreased (Expand Search), reduction reuse (Expand Search), production increases (Expand Search)
linear decrease » linear increase (Expand Search)
reduction decrease » reduction decreased (Expand Search), reduction reuse (Expand Search), production increases (Expand Search)
linear decrease » linear increase (Expand Search)
-
4281
Data_Sheet_2_Antibacterial effects of human mesenchymal stem cells and their derivatives: a systematic review.PDF
Published 2024“…Introduction<p>The growing problem of antimicrobial resistance (AMR) poses a significant challenge to public health; This is partly due to the lack of advancements in the development of novel antibiotics and the pressing need for alternative treatment options. …”
-
4282
Image 3_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.tif
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4283
Image 4_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.tif
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4284
Data_Sheet_1_Antibacterial effects of human mesenchymal stem cells and their derivatives: a systematic review.PDF
Published 2024“…Introduction<p>The growing problem of antimicrobial resistance (AMR) poses a significant challenge to public health; This is partly due to the lack of advancements in the development of novel antibiotics and the pressing need for alternative treatment options. …”
-
4285
Image 2_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.tif
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4286
Video 1_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.avi
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4287
Image 8_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.tif
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4288
Table 2_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.docx
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4289
Table 1_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.docx
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4290
Image 6_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.tif
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4291
Data Sheet 2_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.zip
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4292
Video 2_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.avi
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4293
Image 5_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.tif
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4294
Image 7_The effect of COVID-19 and sex differences on natural killer cell cytotoxicity.tif
Published 2025“…We also observed a notable reduction in the cytotoxic function of NK cells against tumor targets. …”
-
4295
Results for the EPIC bowel subscale and the EORTC QLQ PR25 bowel symptoms scale.
Published 2025“…This is also reflected in the mean and median QoL scores (w.r.t. the right-hand axis), which decreased in magnitude with time also.…”
-
4296
Supplementary Material for: Alcohol use and types and ischemic stroke: a systematic review and meta-analysis
Published 2025“…Moderate and heavy wine use was associated with significant reduction in ischemic stroke risk (RR=0.61; 95% CI 0.45-0.84¸ RR=0.77; 95% CI 0.63- 0.93). …”
-
4297
Data Sheet 1_UV-LED disinfection of emerging Vibrio pathogens: inactivation kinetics and reactivation potential.pdf
Published 2025“…Introduction<p>The Vibrio genus includes aquatic bacteria from freshwater, estuarine, and marine environments, some of which pose significant risks to public and environmental health, highlighting the need for effective disinfection strategies. …”
-
4298
Related to Fig 3.
Published 2025“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX<sup>OE</sup> (mean ± SEM, <i>n</i> = 5) than BT-474_VECT<sup>OE</sup> tumors. …”
-
4299
Table 1_The impact of diagnosis-related group-based medical insurance payment model on the prognosis and nursing care of patients undergoing composite trabeculectomy: a retrospecti...
Published 2025“…Similarly, when comparing follow-up indicators after more than 6 months post-surgery between the two groups, visual acuity (p > 0.05), intraocular pressure (p > 0.05), and field of view (p > 0.05) were not significantly different from baseline.</p>Conclusion<p>This study represents the first empirical validation demonstrating that the implementation of the Diagnosis-Related Groups (DRG)-based medical insurance reform significantly reduced the mean length of hospital stay for patients undergoing compound trabeculectomy (from 8 days to 5 days). …”
-
4300
Data Sheet 1_Efficacy and safety of PCSK9 inhibitors, potent statins, and their combinations for reducing low-density lipoprotein cholesterol in hyperlipidemia patients: a systemat...
Published 2025“…Regarding the efficacy of lipid reduction, four principal medications were evaluated: evolocumab and atorvastatin [mean standard deviation (MD) −3.41, 95% CI −4.81 to −2.00] and evolocumab with rosuvastatin (MD −3.44, 95% CI −5.10 to −1.78) vs. placebo; alirocumab combined with rosuvastatin (MD −2.91, 95% CI −3.95 to −1.88) and alirocumab with atorvastatin (MD −2.90, 95% CI −3.97 to −1.84) vs. placebo. …”